IMMUNORX PHARMA
ImmunoRx Pharma develops an anti-body that treats certain types of chronic inflammatory diseases including ulcerative colitis, rheumatoid arthritis, and Crohn’s disease. The company's antibody targets a new critical target in chronic inflammation and auto-immunity which was originally discovered by Dr. Tessier in Canada.
IMMUNORX PHARMA
Industry:
Health Care Medical Medical Device
Founded:
2020-01-01
Status:
Active
Total Funding:
2.67 M USD
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Equinox
Equinox is a developer of a medical technology in revolutionizing the treatment of glaucoma and other progressive eye diseases.
InTouch Health
InTouch Health is the leader in Acute Care Telemedicine solutions.
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Summit BHC
Summit Behavioral Healthcare is an Atlanta-based provider of addiction treatment and behavioral health services.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
More informations about "ImmunoRx Pharma"
ImmunoRx Pharma Inc. - TVM Capital Life Science …
ImmunoRx Pharma Inc. Investment: 2021. Status: Active. All Portfolio ImmunoRx Pharma, Inc. plans to develop a first-in-class antibody, to proof-of-concept, with the potential to treat certain types of chronic inflammatory diseases, including …See details»
TVM Life Science Innovation II SCSp Announces Investment in …
Luxembourg, January 19 th, 2021 –TVM Life Science Innovation II SCSp today announced the fund’s investment establishing ImmunoRx Pharma, Inc., a company based in Wilmington, …See details»
ImmunoRx Pharma acquired by TVM Capital Life Science
ImmunoRx Pharma ImmunoRx Pharma develops an anti-body that treats certain types of chronic inflammatory diseases. Acquiring Organization: TVM Capital Life Science TVM Capital Life …See details»
ImmunoRx Pharma - PitchBook
ImmunoRx Pharma General Information Description. Developer of novel antibodies designed to treat certain types of chronic inflammatory diseases. The company's antibody cures diseases, …See details»
TVM Capital Life Science - Investments, Portfolio & Company Exits
TVM Capital Life Science has acquired ImmunoRx Pharma on Jan 19, 2021. Unlock for free . Investments. Edit Investments Section. Number of Investments 24. Number of Lead …See details»
ImmunoRx Pharma, Inc. - Drug pipelines, Patents, Clinical trials
Explore ImmunoRx Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial.See details»
ImmunoRx Pharma - Products, Competitors, Financials, Employees ...
ImmunoRx Pharma develops the first-in-class antibody, to proof-of-concept, with the potential to treat certain types of chronic inflammatory diseases, including ulcerative colitis, rheumatoid …See details»
ImmunoRx Pharma | VentureRadar
RDP Pharma Unknown n/a RDP Pharma (RDP) is a privately held biotech, dedicated to the vision that their products will deliver valuable medicines to patients in need. The company's projects …See details»
ImmunoRx - LinkedIn
ImmunoRx | 318 followers on LinkedIn. A subsidiary of Voirx, Focuses on manufacturing cancer oncolytics and immunotherapeutic products ... Chief Executive Officer at ImmunoRx Pharma, …See details»
ImmunoRx Pharma, Inc.: Drug pipelines, Patents, Clinical trials
Explore ImmunoRx Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
IMMUNORX PHARMA, INC. Top 13F Holdings - WhaleWisdom.com
IMMUNORX PHARMA, INC. 1000 N. WEST ST., SUITE 1200 WILMINGTON DE 19801 Business Phone: 6493324417. Recent SEC Filings. Filing Date; D: 2021-02-17: We give you the access …See details»
ImmunoRx Pharma - Funding, Financials, Valuation & Investors
ImmunoRx Pharma has raised a total of . obfuscated. obfuscated. in funding over 1 round. This was a Seed round raised on Feb 16, 2021. Which funding types raised the most money? …See details»
IRX-010 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 IRX-010, Initially developed by ImmunoRx Pharma, Inc., Now, its global highest R&D status is Phase 1, Active Org.: ImmunoRx Pharma, Inc.. Biomedical products. Data. …See details»
ImmunoRx Pharma - CB Insights
See ImmunoRx Pharma funding rounds, investors, investments, exits and more. Evaluate their financials based on ImmunoRx Pharma's post-money valuation and revenue. ImmunoRx …See details»
ImmunoRx Pharma - Crunchbase
Companies like ImmunoRx Pharma include Portal Instruments, Equinox, and Pandion Therapeutics. Tiburio Therapeutics . Cambridge, Massachusetts, United States 1 Contact 1-10 …See details»
Clinical Trial on IRX-010 - Clinical Trials Registry - ICH GCP
Apr 4, 2024 Study Director: ImmunoRx Pharma,Inc, ImmunoRx Pharma Inc. Study record dates These dates track the progress of study record and summary results submissions to …See details»
IRX 010 - AdisInsight - Springer
If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with username/password or try to …See details»
ImmunoRx Pharma - Updates, News, Events, Signals & Triggers
Jan 19, 2021 ImmunoRx Pharma develops an anti-body that treats certain types of chronic inflammatory diseases.See details»
ImmunoRx Pharma - Contacts, Employees, Board Members
ImmunoRx Pharma has 1 current employee profile, CEO Caroline Fortier. Contacts. Edit Contacts Section. We're working on getting contact data for ImmunoRx Pharma . Find more contact …See details»